[Research Report] The anticoagulant reversal drugs market is expected to reach US$ 2,276.54 million by 2027 from US$ 922.55 million in 2019; the market is estimated to grow at a CAGR of 12.6% from 2020 to 2027.
Anticoagulant reversal drugs are required to reverse the effect of anticoagulation in certain situations such as unplanned surgery, overdose of anticoagulant therapy, and uncontrolled bleeding. Anticoagulant reversal drugs are used in medical conditions such as venous thromboembolism, atrial fibrillation (AF), mechanical valve replacement, and other coagulation disorders such as antiphospholipid antibody syndrome and Factor V Leiden. The growth of the anticoagulant reversal drug market growth is mainly attributed to the factors such as rising prevalence of atrial fibrillation (AFib) and stroke. However, the high cost of anticoagulant reversal drugs is restricting the market growth.
Lucrative Regional Markets for Anticoagulant Reversal Drugs
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Rise in Prevalence of Atrial Fibrillation (AFib)
Oral anticoagulants are widely used and are highly effective in preventing thromboembolism among AFib patients. However, the use of anticoagulants may lead to bleeding in AFib patients; thus, anticoagulant reversal drugs are used to prevent bleeding.
As per the Centers for Disease Control and Prevention (CDC), in 2018, in the US, AFib was mentioned on around 175,326 death certificates and was the primary cause of death in about 25,845 of those deaths. Additionally, it has also anticipated that 12.1 million people in the US will have AFib by 2030.
Moreover, according to the European Society of Cardiology (ESC), in 2016, 7.6 million people above 65 years of age in the EU had atrial fibrillation and it is expected that the number will increase by 89% to reach 14.4 million by 2060. Similarly, as per the Stroke Association: State of the Nation 2017, more than 1 million people in the UK suffer from atrial fibrillation.
Thus such high prevalence of atrial fibrillation across the world is likely to favor the growth of the market.
Product-Based Insights
Based on product, the anticoagulant reversal drugs market is segmented into prothrombin complex concentrates, vitamin k, protamine, tranexamic acid, idarucizumab, and AndeXXa. The prothrombin complex concentrates segment held the largest share of the market in 2019; whereas, the AndeXXa segment is estimated to register the highest CAGR in the market during the forecast period. Prothrombin complex concentrates are widely used as a reliable and fast alternative to fresh frozen plasma and controls excessive bleeding.
Anticoagulant Reversal Drug Market, by Product – 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Distribution channel-Based Insights
Based on distribution channel, the anticoagulant reversal drugs market is segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment held the largest share of the market in 2019, and is estimated to register the highest CAGR in the market during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Anticoagulant Reversal Drugs Market: Strategic Insights
Market Size Value in US$ 922.55 Million in 2019 Market Size Value by US$ 2,276.54 Million by 2027 Growth rate CAGR of 12.6% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Anticoagulant Reversal Drugs Market: Strategic Insights
| Market Size Value in | US$ 922.55 Million in 2019 |
| Market Size Value by | US$ 2,276.54 Million by 2027 |
| Growth rate | CAGR of 12.6% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Collaboration is one of the major strategies adopted by the anticoagulant reversal drug market players to enlarge customer base worldwide, which also permits them to maintain their brand name globally.
Anticoagulant Reversal Drugs Market – by Product
- Prothrombin Complex Concentrates
- Vitamin K
- Protamine
- Tranexamic Acid
- Idarucizumab
- AndeXXa
Anticoagulant Reversal Drugs Market – by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
Anticoagulant Reversal Drugs Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South and Central America
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- Boehringer Ingelheim International GmbH
- Pfizer Inc
- Octapharma AG
- Amag Pharmaceuticals, Inc
- Fresenius Kabi AG
- Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
- CSL Limited
- China Biologic Products, Inc
- Grifols, S.A
- Shanghai RAAS Blood Products Co., Ltd.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product , and Distribution channel and Geography.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Anticoagulant reversal drugs are required to reverse the effect of anticoagulation in certain situations such as unplanned surgery, overdose of anticoagulant therapy, and uncontrolled bleeding. In medical conditions such as venous thromboembolism, atrial fibrillation (AF), mechanical valve replacement, and other coagulation disorders such as antiphospholipid antibody syndrome, Factor V Leiden, anticoagulant reversal drugs are used.
The factors that are driving growth of the market are rise in prevalence of atrial fibrillation (AFib) and increase in prevalence of stroke are the major factors driving the market growth. However, high cost of anticoagulant reversal drugs is hindering the market growth.
The anticoagulant reversal drugs market majorly consists of the players such as Boehringer Ingelheim International GmbH; Pfizer Inc; Octapharma AG; Amag Pharmaceuticals, Inc; Fresenius Kabi AG; Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals); CSL Limited; China Biologic Products, Inc; Grifols, S.A, and Shanghai RAAS Blood Products Co., Ltd. amongst others.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Anticoagulant Reversal Drugs Market – By Product
1.3.2 Global Anticoagulant Reversal Drugs Market – By Distribution Channel
1.3.3 Global Anticoagulant Reversal Drugs Market – By Geography
2. Anticoagulant Reversal Drugs Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Anticoagulant Reversal Drugs Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America– PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East & Africa
4.2.5 South & Central America
4.3 Expert Opinion
5. Anticoagulant Reversal Drugs Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Atrial Fibrillation (AFib)
5.1.2 Increase in Prevalence of Stroke
5.2 Market Restraints
5.2.1 High Cost of Anticoagulant Reversal Drugs
5.3 Market Opportunities
5.3.1 Increasing Research Activities on Anticoagulant Reversal Drugs
5.4 Future Trends
5.4.1 Development and Launch of Innovative Products
5.5 Impact Analysis
6. Anticoagulant Reversal Drugs Market – Global Analysis
6.1 Global Anticoagulant Reversal Drugs Market Revenue Forecast And Analysis
6.2 Global Anticoagulant Reversal Drugs Market, By Geography - Forecast And Analysis
6.3 Market Positioning
7. Anticoagulant Reversal Drugs Market– By Product
7.1 Overview
7.2 Anticoagulant Reversal Drugs Market Share, by Product, 2019 and 2027 (%)
7.3 Prothrombin Complex Concentrates
7.3.1 Overview
7.3.2 Prothrombin Complex Concentrates: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
7.4 Vitamin K
7.4.1 Overview
7.4.2 Vitamin K: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
7.5 Protamine
7.5.1 Overview
7.5.2 Protamine: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
7.6 Tranexamic Acid
7.6.1 Overview
7.6.2 Tranexamic Acid: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
7.7 Idarucizumab
7.7.1 Overview
7.7.2 Idarucizumab: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
7.8 Andexxa
7.8.1 Overview
7.8.2 Andexxa: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
8. Anticoagulant Reversal Drugs Market– By Distribution Channel
8.1 Overview
8.2 Anticoagulant Reversal Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
8.4 Retail Pharmacies
8.4.1 Overview
8.4.2 Retail Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
9. Anticoagulant Reversal Drugs Market – Geographic Analysis
9.1 North America: Anticoagulant Reversal Drugs Market
9.1.1 Overview
9.1.2 North America: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Anticoagulant Reversal Drugs Market, by Product, 2018–2027 (USD Million)
9.1.4 North America: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)
9.1.5 North America: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
9.1.6 US: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Anticoagulant Reversal Drugs Market, by Product, 2018–2027 (USD Million)
9.1.6.3 US: Anticoagulant Reversal Drugs Market, by Distribution Channel 2018–2027 (USD Million)
9.1.7 Canada: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Anticoagulant Reversal Drugs Market, by Product, 2018–2027 (USD Million)
9.1.7.3 Canada: Anticoagulant Reversal Drugs Market, by Distribution Channel 2018–2027 (USD Million)
9.1.8 Mexico: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Anticoagulant Reversal Drugs Market, by Product, 2018–2027 (USD Million)
9.1.8.3 Mexico: Anticoagulant Reversal Drugs Market, by Distribution Channel 2018–2027 (USD Million)
9.2 Europe: Anticoagulant Reversal Drugs Market
9.2.1 Overview
9.2.2 Europe: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.2.3 Europe: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.2.4 Europe: Anticoagulant Reversal Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.2.5 Europe: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
9.2.6 Germany: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.2.6.1 Germany: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.2.6.2 Germany: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.2.6.3 Germany: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.2.7 France: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.2.7.1 France: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.2.7.2 France: Anticoagulant Reversal Drugs Market, by Product– Revenue and Forecast to 2027 (USD Million)
9.2.7.3 France: Anticoagulant Reversal Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.2.8 UK: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.2.8.1 UK: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.2.8.2 UK: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.2.8.3 UK: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.2.9 Italy: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.2.9.1 Italy: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.2.9.2 Italy: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.2.9.3 Italy: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.2.10 Spain: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.2.10.1 Spain: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.2.10.2 Spain: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.2.10.3 Spain: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.2.11 Rest of Europe: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.2.11.1 Rest of Europe: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.2.11.2 Rest of Europe: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.2.11.3 Rest of Europe: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.3 Asia Pacific: Anticoagulant Reversal Drugs Market
9.3.1 Overview
9.3.2 Asia Pacific: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
9.3.3 Asia Pacific: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.3.4 Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.3.5 Asia Pacific: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
9.3.6 China: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.3.6.1 China: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.3.6.2 China: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.3.6.3 China: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.3.7 Japan: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.3.7.1 Japan: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.3.7.2 Japan: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.3.7.3 Japan: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.3.8 India: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.3.8.1 India: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.3.8.2 India: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.3.8.3 India: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.3.9 South Korea: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.3.9.1 South Korea: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.3.9.2 South Korea: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.3.9.3 South Korea: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.3.10 Australia: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.3.10.1 Australia: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.3.10.2 Australia: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.3.10.3 Australia: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.3.11 Rest of Asia Pacific: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.3.11.1 Rest of Asia Pacific: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.3.11.2 Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.3.11.3 Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.4 Middle East & Africa: Anticoagulant Reversal Drugs Market
9.4.1 Overview
9.4.2 Middle East & Africa: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
9.4.3 Middle East & Africa Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.4.4 Middle East & Africa Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.4.5 Middle East & Africa: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
9.4.6 Saudi Arabia: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.4.6.1 Saudi Arabia: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.4.6.2 Saudi Arabia Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.4.6.3 Saudi Arabia Anticoagulant Reversal Drugs Market, Type – Revenue and Forecast to 2027 (USD Million)
9.4.7 UAE: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.4.7.1 UAE: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.4.7.2 UAE Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.4.7.3 UAE Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.4.8 South Africa: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.4.8.1 South Africa: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.4.8.2 South Africa Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.4.8.3 South Africa Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.4.9 Rest of Middle East and Africa: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.4.9.1 Rest of Middle East and Africa: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.4.9.2 Rest of Middle East and Africa Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.4.9.3 Rest of Middle East and Africa Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.5 South and Central America: Anticoagulant Reversal Drugs Market
9.5.1 Overview
9.5.2 South and Central America: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.5.3 South and Central America: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.5.4 South and Central America: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.5.5 South and Central America: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
9.5.6 Brazil: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.5.6.1 Brazil: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.5.6.2 Brazil: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.5.6.3 Brazil: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.5.7 Argentina: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.5.7.1 Argentina: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.5.7.2 Argentina: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.5.7.3 Argentina: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.5.8 Rest of South and Central America: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.5.8.1 Rest of South and Central America: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.5.8.2 Rest of South and Central America: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.5.8.3 Rest of South and Central America: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10. Impact of COVID-19 Pandemic on Global Anticoagulant Reversal Drugs Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Anticoagulant Reversal Drugs Market– Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.3.2 Organic Developments Done By Companies
11.4 Inorganic Developments
11.4.1 Overview
11.4.2 Inorganic Developments Done By Companies
12. Company Profiles
12.1 Boehringer Ingelheim International GmbH
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Pfizer Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Octapharma AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 AMAG PHARMACEUTICALS, INC.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Fresenius Kabi AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 CSL Limited
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 China Biologic Products, Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Grifols, S.A.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Shanghai RAAS Blood Products Co., Ltd.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 Glossary of Terms
LIST OF TABLES
Table 1. North America Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 2. North America Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 3. US Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 4. US Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 5. Canada Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 6. Canada Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 7. Mexico Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 8. Mexico Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 9. Europe: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 10. Europe: Anticoagulant Reversal Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 11. Germany: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 12. Germany: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. France: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. France: Anticoagulant Reversal Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 15. UK: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 16. UK: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 17. Italy: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 18. Italy: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 19. Spain: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 20. Spain: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 21. Rest of Europe: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 22. Rest of Europe: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 23. Asia Pacific: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 24. Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 25. China: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 26. China: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 27. Japan: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 28. Japan: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 29. India: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 30. India: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 31. South Korea: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 32. South Korea: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 33. Australia: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 34. Australia: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 35. Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 36. Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 37. Middle East & Africa Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 38. Middle East & Africa Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 39. Saudi Arabia Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 40. Saudi Arabia Anticoagulant Reversal Drugs Market, Type – Revenue and Forecast to 2027 (USD Million)
Table 41. UAE Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 42. UAE Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 43. South Africa Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 44. South Africa: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 45. Rest of Middle East and Africa Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 46. Rest of Middle East and Africa Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 47. South and Central America: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 48. South and Central America: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 49. Brazil: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 50. Brazil: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 51. Argentina: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 52. Argentina: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 53. Rest of South and Central America: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 54. Rest of South and Central America: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 55. Glossary of Terms, Anticoagulant Reversal Drugs Market
LIST OF FIGURES
Figure 1. Anticoagulant Reversal Drugs Market Segmentation
Figure 2. Anticoagulant Reversal Drugs Market, By Region
Figure 3. Global Anticoagulant Reversal Drugs Market Overview
Figure 4. Prothrombin Complex Concentrates Segment Held Largest Share of Product Segment In Anticoagulant Reversal Drugs Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Anticoagulant Reversal Drugs Market, By Geography (USD Million)
Figure 7. Global Anticoagulant Reversal Drugs Market- Leading Country Markets (USD Million)
Figure 8. Global Anticoagulant Reversal Drugs Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa Analysis
Figure 13. South & Central America PEST Analysis
Figure 14. Expert Opinion
Figure 15. Anticoagulant Reversal Drugs Market Impact Analysis of Drivers and Restraints
Figure 16. Global Anticoagulant Reversal Drugs Market – Revenue Forecast And Analysis – 2019- 2027
Figure 17. Global Anticoagulant Reversal Drugs Market – By Geography Forecast and Analysis – 2019- 2027
Figure 18. Global Anticoagulant Reversal Drugs Market – By Geography Forecast and Analysis – 2019- 2027
Figure 19. Anticoagulant Reversal Drugs Market Share, by Product, 2019 and 2027 (%)
Figure 20. Prothrombin Complex Concentrates: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 21. Vitamin K: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 22. Protamine: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 23. Tranexamic Acid: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 24. Idarucizumab: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 25. Andexxa: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 26. Anticoagulant Reversal Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)
Figure 27. Hospital Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 28. Retail Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 29. Others: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 30. North America: Anticoagulant Reversal Drugs Market, by Key Country – Revenue (2019) (USD Million)
Figure 31. North America Anticoagulant Reversal Drugs Market Revenue and Forecast to 2027 (USD Million)
Figure 32. North America: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
Figure 33. US: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. Canada: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Mexico: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. Europe: Anticoagulant Reversal Drugs Market, by Key Country – Revenue (2019) (USD Million)
Figure 37. Europe: Anticoagulant Reversal Drugs Market Revenue and Forecast to 2027 (USD Million)
Figure 38. Europe: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
Figure 39. Germany: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 40. France: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 41. UK: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 42. Italy: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 43. Spain: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 44. Rest of Europe: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 45. Asia Pacific: Anticoagulant Reversal Drugs Market, by Key Country – Revenue (2019) (USD Million)
Figure 46. Asia Pacific: Anticoagulant Reversal Drugs Market Revenue and Forecast to 2027 (USD Million)
Figure 47. Asia Pacific: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
Figure 48. China: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 49. Japan: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 50. India: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 51. South Korea: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 52. Australia: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 53. Rest of Asia Pacific: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 54. Middle East & Africa: Anticoagulant Reversal Drugs Market, by Key Country – Revenue (2019) (USD Million)
Figure 55. Middle East & Africa Anticoagulant Reversal Drugs Market Revenue and Forecast to 2027 (USD Million)
Figure 56. Middle East & Africa: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
Figure 57. Saudi Arabia: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 58. UAE: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 59. South Africa: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 60. Rest of Middle East and Africa: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 61. South and Central America: Anticoagulant Reversal Drugs Market, by Key Country – Revenue (2019) (USD Million)
Figure 62. South and Central America: Anticoagulant Reversal Drugs Market Revenue and Forecast to 2027 (USD Million)
Figure 63. South and Central America: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
Figure 64. Brazil: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 65. Argentina: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 66. Rest of South and Central America: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 67. Impact of COVID-19 Pandemic in North American Country Markets
Figure 68. Impact of COVID-19 Pandemic in European Country Markets
Figure 69. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 70. Impact of COVID-19 Pandemic in Middle East and Africa Market
Figure 71. Impact of COVID-19 Pandemic in South and Central America Market
Figure 72. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Anticoagulant Reversal Drugs Market
- Boehringer Ingelheim International GmbH
- Pfizer Inc.
- Octapharma AG
- AMAG PHARMACEUTICALS, INC.
- Fresenius Kabi AG
- Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
- CSL Limited
- China Biologic Products, Inc
- Grifols, S.A.
- Shanghai RAAS Blood Products Co.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Anticoagulant Reversal Drugs Market
Jan 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jan 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jan 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jan 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jan 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)